Proficio Capital Partners LLC Cti Biopharma Corp Transaction History

Proficio Capital Partners LLC

  • $969 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023
BUY
$4.2 - $6.01 $50,131 - $71,735
11,936 New
11,936 $50,000
Q3 2019

Nov 13, 2019
SELL
$0.64 - $0.92 $1,128 - $1,621
-1,763 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$0.8 - $1.03 $1,410 - $1,815
1,763 New
1,763 $2,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email